NYSE$PRA

ProAssurance Corporation · Q2 2021 earnings

Q2 2021 earnings · · Investor relations

Briefing

Reported net income and operating income for the second quarter of 2021.

ProAssurance Corporation reported a net income of $92.1 million and an operating income of $26.6 million for the three months ended June 30, 2021. The consolidated net income includes a $74.4 million gain on bargain purchase related to the acquisition of NORCAL, partially offset by $20.3 million of pre-tax transaction-related costs. Excluding the gain on bargain purchase, transaction-related costs, and the related tax effects, net income was $34.1 million.

  • Consolidated net income includes a $74.4 million gain on bargain purchase related to the acquisition of NORCAL, partially offset by $20.3 million of pre-tax transaction-related costs.
  • Consolidated combined ratio, excluding transaction-related costs, of 99.9%.
  • Profitability in all segments, driven by top line growth in all segments except the Lloyd’s Syndicates segment.
  • 28.1 point improvement in the consolidated current accident year net loss ratio.

Headline financials

Total Revenue

$282M

Previous: $222M+27.0%
EPS (adj)

$0.49

Previous: -$0.60+181.7%
Free Cash Flow

$92.1M

Previous: -$18.1M+608.6%
Net Income

$92.1M

Previous: -$18.1M+608.6%
Operating Income

$21.4M

Previous: -$47.9M+144.6%
Gross Profit

$73.1M

Previous: -$14.6M+600.9%
Cash & Equivalents

$161M

Previous: $224M-28.3%
Total Assets

$6.36B

Previous: $4.78B+32.9%
Stock-Based Comp

$1.15M

Previous: $1.02M+12.9%

Revenue & EPS history

ProAssurance · Revenue · Quarterly

$282M

Q2 2021+27%vs Q2 2020
Beat estimate in 6 of 16 quarters(38%)
ActualEstimate

Revenue by segment

ProAssurance · $242M total across 4 segments · Q2 2021

  • Specialty P&C
    $170M+32.7%
  • Workers' Compensation Insurance
    $41.5M-3.3%
  • Corporate
    $26.8M
  • Segregated Portfolio Cell Reinsurance
    $3.82M-77.6%

Forward guidance

The operating environment remains uncertain, as we and others in our industry seek to better understand the long-term impacts of the pandemic and navigate the current loss environment in the healthcare professional liability marketplace.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q2 2021

Historical avgQ2 2021

-0.4%

Avg return

Earnings day

-1.1%

Avg return

5 days after

-0.7%

Avg return

30 days after

56%

38 / 68 earnings

Positive

+18.1%

Q2 2024

Best reaction

-22.1%

Q3 2023

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+0.0%+0.2%-0.5%
Q4 2025+0.4%+0.6%+1.3%
Q3 2025+0.2%+0.3%-0.4%
Q1 2025-0.2%+0.2%+0.8%
Q4 2024+14.3%+10.8%+65.5%
Q3 2024+3.0%+3.7%+2.5%
Q2 2024+18.1%+15.5%+14.6%
Q1 2024+9.6%+6.9%+0.7%
Q4 2023-4.7%+0.2%-0.8%
Q3 2023-22.1%-27.6%-27.7%
Q2 2023+8.2%+8.2%+3.7%
Q1 2023-21.5%-21.3%-22.5%
Q4 2022+4.7%+3.7%-5.9%
Q3 2022-12.7%-11.2%-14.4%
Q2 2022+6.1%+6.7%-4.3%
Q1 2022-12.7%-15.0%-8.0%
Q4 2021+1.1%-0.9%+3.4%
Q3 2021-0.9%-2.0%-6.3%
Q2 2021+5.4%+17.5%+23.7%
Q1 2021+1.1%-3.1%-6.8%
Q4 2020+5.0%+5.6%+13.7%
Q3 2020-10.2%+2.0%+8.6%
Q2 2020-2.1%-5.1%-12.2%
Q1 2020-18.0%-22.1%-17.0%
Q4 2019-0.2%-5.4%-22.7%
Q3 2019+1.4%-1.6%-5.3%
Q2 2019-0.6%+1.6%+3.7%
Q1 2019-0.9%+4.2%+6.7%
Q4 2018-3.7%-9.3%-22.3%
Q3 2018+4.2%-0.4%-4.9%
Q2 2018+5.5%+6.8%+16.1%
Q1 2018-13.5%-12.7%-17.2%
Q4 2017-6.9%-5.4%-7.5%
Q3 2017+6.1%+5.5%+7.7%
Q2 2017-5.0%-6.0%-10.7%
Q1 2017+1.1%-2.4%-1.0%
Q4 2016+8.9%+4.9%+4.0%
Q3 2016-2.5%-1.6%+10.6%
Q2 2016+2.4%+5.4%+5.7%
Q1 2016+1.1%
Q4 2015-3.3%
Q3 2015-0.9%
Q2 2015+0.1%
Q1 2015-3.5%
Q4 2014+0.1%
Q3 2014-4.9%
Q2 2014-0.4%
Q1 2014-0.6%
Q4 2013-2.2%
Q3 2013+2.7%
Q2 2013-6.3%
Q1 2013+0.1%
Q4 2012+0.9%
Q3 2012-1.9%
Q2 2012+0.9%
Q1 2012+1.5%
Q4 2011+5.7%
Q4 2010+5.7%
Q3 2011+2.0%
Q2 2011+1.8%
Q1 2010+0.4%
Q1 2011+0.6%
Q4 2008+8.2%
Q3 2009+4.2%
Q3 2010+4.2%
Q2 2010-3.5%
Q2 2009-3.5%
Q4 2009-3.5%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro